5ht2 agonists for controlling IOP and treating glaucoma

Details 5ht2 agonists for controlling IOP and treating glaucoma 5ht2 agonists for controlling IOP and treating glaucoma

2005-08-09

2005-08-09

Krass, Frederick (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S405000, C514S912000, C514S913000

Reexamination Certificate

active

06927233

ABSTRACT:
Compositions and methods for controlling intraocular pressure and treating glaucoma using 1-(2-aminopropyl)-indazol-6-ol are disclosed.

REFERENCES:
patent: 3994890 (1976-11-01), Fujimura et al.
patent: 4690931 (1987-09-01), Wick et al.
patent: 5151444 (1992-09-01), Ueno et al.
patent: 5296504 (1994-03-01), Stjernschantz et al.
patent: 5352708 (1994-10-01), Woodward et al.
patent: 5422368 (1995-06-01), Stjernschantz et al.
patent: 5889052 (1999-03-01), Klimko et al.
patent: 6664286 (2003-12-01), May et al.
patent: WO 94/13275 (1994-06-01), None
patent: WO 98/30548 (1998-07-01), None
patent: WO 00/16761 (2000-03-01), None
patent: WO 01/40183 (2001-06-01), None
Osborne, Neville N., “Serotonin and melatonin in the iris/ciliary processes and their involvement in intraocular pressure”, ACTA Neurobiol. Exp., 54 (Suppl.) 57-64 (1994).

Affiliated with

Also associated with

Rating

5ht2 agonists for controlling IOP and treating glaucoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5ht2 agonists for controlling IOP and treating glaucoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5ht2 agonists for controlling IOP and treating glaucoma will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3508955